Pharma & Healthcare
Global Drugs for Schistosomiasis Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 11, 25
- ID: 304469
- Pages: 138
- Figures: 132
- Views: 1
In 2024, the global market size of Drugs for Schistosomiasis was estimated to be worth US$ 88.3 million and is forecast to reach approximately US$ 114 million by 2031 with a CAGR of 3.8% during the forecast period 2025-2031.
Schistosomiasis, also known as snail fever and bilharzia, is a disease caused by parasitic flatworms called schistosomes. The urinary tract or the intestines may be infected. Signs and symptoms may include abdominal pain, diarrhea, bloody stool, or blood in the urine. Those who have been infected a long time may experience liver damage, kidney failure, infertility, or bladder cancer. In children, it may cause poor growth and learning difficulty.
Shin Poong, Merck, Bayer, EIPICO, Chandra Bhagat Pharma and Taj Pharmaceuticals are the main manufacturers of drugs for Schistosomiasis.
East Africa is the largest region of drugs for Schistosomiasis, whose market share is about 24%,
Followed by West Africa(20%).
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drugs for Schistosomiasis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Schistosomiasis.
The Drugs for Schistosomiasis market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drugs for Schistosomiasis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drugs for Schistosomiasis manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
Shin Poong
Merck
Bayer
EIPICO
Chandra Bhagat Pharma
Taj Pharmaceuticals
Segment by Type
Praziquantel
Oxamniquine
Other
Segment by Application
S. haematobium
S. mansoni
S. japonicum
S. mekongi
S. intercalatum
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Drugs for Schistosomiasis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Drugs for Schistosomiasis manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drugs for Schistosomiasis sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Schistosomiasis, also known as snail fever and bilharzia, is a disease caused by parasitic flatworms called schistosomes. The urinary tract or the intestines may be infected. Signs and symptoms may include abdominal pain, diarrhea, bloody stool, or blood in the urine. Those who have been infected a long time may experience liver damage, kidney failure, infertility, or bladder cancer. In children, it may cause poor growth and learning difficulty.
Shin Poong, Merck, Bayer, EIPICO, Chandra Bhagat Pharma and Taj Pharmaceuticals are the main manufacturers of drugs for Schistosomiasis.
East Africa is the largest region of drugs for Schistosomiasis, whose market share is about 24%,
Followed by West Africa(20%).
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drugs for Schistosomiasis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Schistosomiasis.
The Drugs for Schistosomiasis market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drugs for Schistosomiasis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drugs for Schistosomiasis manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
Shin Poong
Merck
Bayer
EIPICO
Chandra Bhagat Pharma
Taj Pharmaceuticals
Segment by Type
Praziquantel
Oxamniquine
Other
Segment by Application
S. haematobium
S. mansoni
S. japonicum
S. mekongi
S. intercalatum
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Drugs for Schistosomiasis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Drugs for Schistosomiasis manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drugs for Schistosomiasis sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
1 Study Coverage
1.1 Drugs for Schistosomiasis Product Introduction
1.2 Market by Type
1.2.1 Global Drugs for Schistosomiasis Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Praziquantel
1.2.3 Oxamniquine
1.2.4 Other
1.3 Market by Application
1.3.1 Global Drugs for Schistosomiasis Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 S. haematobium
1.3.3 S. mansoni
1.3.4 S. japonicum
1.3.5 S. mekongi
1.3.6 S. intercalatum
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Drugs for Schistosomiasis Market Size Estimates and Forecasts
2.1.1 Global Drugs for Schistosomiasis Revenue 2020-2031
2.1.2 Global Drugs for Schistosomiasis Sales 2020-2031
2.2 Drugs for Schistosomiasis Market Size by Region: 2024 Versus 2031
2.3 Drugs for Schistosomiasis Sales by Region (2020-2031)
2.3.1 Global Drugs for Schistosomiasis Sales by Region: 2020-2025
2.3.2 Global Drugs for Schistosomiasis Sales Forecast by Region (2026-2031)
2.3.3 Global Drugs for Schistosomiasis Sales Market Share by Region (2020-2031)
2.4 Drugs for Schistosomiasis Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Drugs for Schistosomiasis Revenue by Region: 2020-2025
2.4.2 Global Drugs for Schistosomiasis Revenue Forecast by Region (2026-2031)
2.4.3 Global Drugs for Schistosomiasis Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Drugs for Schistosomiasis Sales by Type (2020-2031)
3.1.1.1 Global Drugs for Schistosomiasis Sales Volume by Type (2020-2031)
3.1.1.2 Global Drugs for Schistosomiasis Sales Market Share by Type (2020-2031)
3.1.2 Global Drugs for Schistosomiasis Revenue by Type (2020-2031)
3.1.2.1 Global Drugs for Schistosomiasis Revenue by Type (2020-2031)
3.1.2.2 Global Drugs for Schistosomiasis Revenue Market Share by Type (2020-2031)
3.1.3 Drugs for Schistosomiasis Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Drugs for Schistosomiasis Sales by Application (2020-2031)
3.2.1.1 Global Drugs for Schistosomiasis Sales Volume by Application (2020-2031)
3.2.1.2 Global Drugs for Schistosomiasis Sales Market Share by Application (2020-2031)
3.2.2 Global Drugs for Schistosomiasis Revenue by Application (2020-2031)
3.2.2.1 Global Drugs for Schistosomiasis Revenue by Application (2020-2031)
3.2.2.2 Global Drugs for Schistosomiasis Revenue Market Share by Application (2020-2031)
3.2.3 Drugs for Schistosomiasis Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Praziquantel of Drugs for Schistosomiasis Revenue Market Share by Application
3.3.2 Oxamniquine of Drugs for Schistosomiasis Revenue Market Share by Application
3.3.3 Other of Drugs for Schistosomiasis Revenue Market Share by Application
4 Global Drugs for Schistosomiasis by Manufacturers
4.1 Global Top Drugs for Schistosomiasis Manufacturers by Sales (2020-2025)
4.1.1 Global Drugs for Schistosomiasis Sales by Manufacturer (2020-2025)
4.1.2 Global Drugs for Schistosomiasis Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Drugs for Schistosomiasis Manufacturers by Revenue (2020-2025)
4.2.1 Global Drugs for Schistosomiasis Revenue by Manufacturer (2020-2025)
4.2.2 Global Drugs for Schistosomiasis Revenue Share by Manufacturer (2020-2025)
4.3 Global Drugs for Schistosomiasis Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Drugs for Schistosomiasis Manufacturers Covered: Ranking by Revenue
4.4.2 Global Drugs for Schistosomiasis Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Drugs for Schistosomiasis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Drugs for Schistosomiasis Manufacturing Base Distribution, Product Type
4.5.1 Drugs for Schistosomiasis Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Drugs for Schistosomiasis Market
4.5.3 Manufacturers Drugs for Schistosomiasis Product Type and Application
4.5.4 Praziquantel Market Sales of Drugs for Schistosomiasis by Manufacturer
4.5.5 Oxamniquine Market Sales of Drugs for Schistosomiasis by Manufacturer
4.5.6 Other Market Sales of Drugs for Schistosomiasis by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Shin Poong
5.1.1 Shin Poong Company Information
5.1.2 Shin Poong Description, Business Overview
5.1.3 Shin Poong Drugs for Schistosomiasis Products Offered
5.1.4 Shin Poong Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Shin Poong Drugs for Schistosomiasis Sales by Product in 2024
5.1.6 Shin Poong Drugs for Schistosomiasis Sales by Application in 2024
5.1.7 Shin Poong Drugs for Schistosomiasis Sales by Geographic Area in 2024
5.1.8 Shin Poong Recent Developments
5.2 Merck
5.2.1 Merck Company Information
5.2.2 Merck Description, Business Overview
5.2.3 Merck Drugs for Schistosomiasis Products Offered
5.2.4 Merck Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Merck Drugs for Schistosomiasis Sales by Product in 2024
5.2.6 Merck Drugs for Schistosomiasis Sales by Application in 2024
5.2.7 Merck Drugs for Schistosomiasis Sales by Geographic Area in 2024
5.2.8 Merck Recent Developments
5.3 Bayer
5.3.1 Bayer Company Information
5.3.2 Bayer Description, Business Overview
5.3.3 Bayer Drugs for Schistosomiasis Products Offered
5.3.4 Bayer Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Bayer Drugs for Schistosomiasis Sales by Product in 2024
5.3.6 Bayer Drugs for Schistosomiasis Sales by Application in 2024
5.3.7 Bayer Drugs for Schistosomiasis Sales by Geographic Area in 2024
5.3.8 Bayer Recent Developments
5.4 EIPICO
5.4.1 EIPICO Company Information
5.4.2 EIPICO Description, Business Overview
5.4.3 EIPICO Drugs for Schistosomiasis Products Offered
5.4.4 EIPICO Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2020-2025)
5.4.5 EIPICO Drugs for Schistosomiasis Sales by Product in 2024
5.4.6 EIPICO Drugs for Schistosomiasis Sales by Application in 2024
5.4.7 EIPICO Drugs for Schistosomiasis Sales by Geographic Area in 2024
5.4.8 EIPICO Recent Developments
5.5 Chandra Bhagat Pharma
5.5.1 Chandra Bhagat Pharma Company Information
5.5.2 Chandra Bhagat Pharma Description, Business Overview
5.5.3 Chandra Bhagat Pharma Drugs for Schistosomiasis Products Offered
5.5.4 Chandra Bhagat Pharma Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Chandra Bhagat Pharma Drugs for Schistosomiasis Sales by Product in 2024
5.5.6 Chandra Bhagat Pharma Drugs for Schistosomiasis Sales by Application in 2024
5.5.7 Chandra Bhagat Pharma Drugs for Schistosomiasis Sales by Geographic Area in 2024
5.5.8 Chandra Bhagat Pharma Recent Developments
5.6 Taj Pharmaceuticals
5.6.1 Taj Pharmaceuticals Company Information
5.6.2 Taj Pharmaceuticals Description, Business Overview
5.6.3 Taj Pharmaceuticals Drugs for Schistosomiasis Products Offered
5.6.4 Taj Pharmaceuticals Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Taj Pharmaceuticals Drugs for Schistosomiasis Sales by Product in 2024
5.6.6 Taj Pharmaceuticals Drugs for Schistosomiasis Sales by Application in 2024
5.6.7 Taj Pharmaceuticals Drugs for Schistosomiasis Sales by Geographic Area in 2024
5.6.8 Taj Pharmaceuticals Recent Developments
6 North America
6.1 North America Drugs for Schistosomiasis Market Size YoY Growth 2020-2031
6.2 North America Drugs for Schistosomiasis Market Facts & Figures by Country
6.2.1 North America Drugs for Schistosomiasis Sales by Country (2020-2031)
6.2.2 North America Drugs for Schistosomiasis Revenue by Country (2020-2031)
6.3 North America Drugs for Schistosomiasis Sales by Type (2020-2025)
6.4 North America Drugs for Schistosomiasis Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Drugs for Schistosomiasis Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Drugs for Schistosomiasis Market Facts & Figures by Region
7.2.1 Asia-Pacific Drugs for Schistosomiasis Sales by Region (2020-2031)
7.2.2 Asia-Pacific Drugs for Schistosomiasis Revenue by Region (2020-2031)
7.3 Asia-Pacific Drugs for Schistosomiasis Sales by Type (2020-2025)
7.4 Asia-Pacific Drugs for Schistosomiasis Sales by Application (2020-2025)
8 Europe
8.1 Europe Drugs for Schistosomiasis Market Size YoY Growth 2020-2031
8.2 Europe Drugs for Schistosomiasis Market Facts & Figures by Country
8.2.1 Europe Drugs for Schistosomiasis Sales by Country (2020-2031)
8.2.2 Europe Drugs for Schistosomiasis Revenue by Country (2020-2031)
8.3 Europe Drugs for Schistosomiasis Sales by Type (2020-2025)
8.4 Europe Drugs for Schistosomiasis Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Drugs for Schistosomiasis Market Size YoY Growth 2020-2031
9.2 Latin America Drugs for Schistosomiasis Market Facts & Figures by Country
9.2.1 Latin America Drugs for Schistosomiasis Sales by Country (2020-2031)
9.2.2 Latin America Drugs for Schistosomiasis Revenue by Country (2020-2031)
9.3 Latin America Drugs for Schistosomiasis Sales by Type (2020-2025)
9.4 Latin America Drugs for Schistosomiasis Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Drugs for Schistosomiasis Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Drugs for Schistosomiasis Market Facts & Figures by Country
10.2.1 Middle East and Africa Drugs for Schistosomiasis Sales by Country (2020-2031)
10.2.2 Middle East and Africa Drugs for Schistosomiasis Revenue by Country (2020-2031)
10.3 Middle East and Africa Drugs for Schistosomiasis Sales by Type (2020-2025)
10.4 Middle East and Africa Drugs for Schistosomiasis Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Drugs for Schistosomiasis Supply Chain Analysis
11.2 Drugs for Schistosomiasis Key Raw Materials and Upstream Suppliers
11.3 Drugs for Schistosomiasis Clients Analysis
11.4 Drugs for Schistosomiasis Sales Channel and Sales Model Analysis
11.4.1 Drugs for Schistosomiasis Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Drugs for Schistosomiasis Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Drugs for Schistosomiasis Distributors
12 Drugs for Schistosomiasis Market Dynamics
12.1 Drugs for Schistosomiasis Industry Trends
12.2 Drugs for Schistosomiasis Market Drivers
12.3 Drugs for Schistosomiasis Market Challenges
12.4 Drugs for Schistosomiasis Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Drugs for Schistosomiasis Product Introduction
1.2 Market by Type
1.2.1 Global Drugs for Schistosomiasis Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Praziquantel
1.2.3 Oxamniquine
1.2.4 Other
1.3 Market by Application
1.3.1 Global Drugs for Schistosomiasis Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 S. haematobium
1.3.3 S. mansoni
1.3.4 S. japonicum
1.3.5 S. mekongi
1.3.6 S. intercalatum
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Drugs for Schistosomiasis Market Size Estimates and Forecasts
2.1.1 Global Drugs for Schistosomiasis Revenue 2020-2031
2.1.2 Global Drugs for Schistosomiasis Sales 2020-2031
2.2 Drugs for Schistosomiasis Market Size by Region: 2024 Versus 2031
2.3 Drugs for Schistosomiasis Sales by Region (2020-2031)
2.3.1 Global Drugs for Schistosomiasis Sales by Region: 2020-2025
2.3.2 Global Drugs for Schistosomiasis Sales Forecast by Region (2026-2031)
2.3.3 Global Drugs for Schistosomiasis Sales Market Share by Region (2020-2031)
2.4 Drugs for Schistosomiasis Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Drugs for Schistosomiasis Revenue by Region: 2020-2025
2.4.2 Global Drugs for Schistosomiasis Revenue Forecast by Region (2026-2031)
2.4.3 Global Drugs for Schistosomiasis Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Drugs for Schistosomiasis Sales by Type (2020-2031)
3.1.1.1 Global Drugs for Schistosomiasis Sales Volume by Type (2020-2031)
3.1.1.2 Global Drugs for Schistosomiasis Sales Market Share by Type (2020-2031)
3.1.2 Global Drugs for Schistosomiasis Revenue by Type (2020-2031)
3.1.2.1 Global Drugs for Schistosomiasis Revenue by Type (2020-2031)
3.1.2.2 Global Drugs for Schistosomiasis Revenue Market Share by Type (2020-2031)
3.1.3 Drugs for Schistosomiasis Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Drugs for Schistosomiasis Sales by Application (2020-2031)
3.2.1.1 Global Drugs for Schistosomiasis Sales Volume by Application (2020-2031)
3.2.1.2 Global Drugs for Schistosomiasis Sales Market Share by Application (2020-2031)
3.2.2 Global Drugs for Schistosomiasis Revenue by Application (2020-2031)
3.2.2.1 Global Drugs for Schistosomiasis Revenue by Application (2020-2031)
3.2.2.2 Global Drugs for Schistosomiasis Revenue Market Share by Application (2020-2031)
3.2.3 Drugs for Schistosomiasis Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Praziquantel of Drugs for Schistosomiasis Revenue Market Share by Application
3.3.2 Oxamniquine of Drugs for Schistosomiasis Revenue Market Share by Application
3.3.3 Other of Drugs for Schistosomiasis Revenue Market Share by Application
4 Global Drugs for Schistosomiasis by Manufacturers
4.1 Global Top Drugs for Schistosomiasis Manufacturers by Sales (2020-2025)
4.1.1 Global Drugs for Schistosomiasis Sales by Manufacturer (2020-2025)
4.1.2 Global Drugs for Schistosomiasis Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Drugs for Schistosomiasis Manufacturers by Revenue (2020-2025)
4.2.1 Global Drugs for Schistosomiasis Revenue by Manufacturer (2020-2025)
4.2.2 Global Drugs for Schistosomiasis Revenue Share by Manufacturer (2020-2025)
4.3 Global Drugs for Schistosomiasis Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Drugs for Schistosomiasis Manufacturers Covered: Ranking by Revenue
4.4.2 Global Drugs for Schistosomiasis Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Drugs for Schistosomiasis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Drugs for Schistosomiasis Manufacturing Base Distribution, Product Type
4.5.1 Drugs for Schistosomiasis Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Drugs for Schistosomiasis Market
4.5.3 Manufacturers Drugs for Schistosomiasis Product Type and Application
4.5.4 Praziquantel Market Sales of Drugs for Schistosomiasis by Manufacturer
4.5.5 Oxamniquine Market Sales of Drugs for Schistosomiasis by Manufacturer
4.5.6 Other Market Sales of Drugs for Schistosomiasis by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Shin Poong
5.1.1 Shin Poong Company Information
5.1.2 Shin Poong Description, Business Overview
5.1.3 Shin Poong Drugs for Schistosomiasis Products Offered
5.1.4 Shin Poong Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Shin Poong Drugs for Schistosomiasis Sales by Product in 2024
5.1.6 Shin Poong Drugs for Schistosomiasis Sales by Application in 2024
5.1.7 Shin Poong Drugs for Schistosomiasis Sales by Geographic Area in 2024
5.1.8 Shin Poong Recent Developments
5.2 Merck
5.2.1 Merck Company Information
5.2.2 Merck Description, Business Overview
5.2.3 Merck Drugs for Schistosomiasis Products Offered
5.2.4 Merck Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Merck Drugs for Schistosomiasis Sales by Product in 2024
5.2.6 Merck Drugs for Schistosomiasis Sales by Application in 2024
5.2.7 Merck Drugs for Schistosomiasis Sales by Geographic Area in 2024
5.2.8 Merck Recent Developments
5.3 Bayer
5.3.1 Bayer Company Information
5.3.2 Bayer Description, Business Overview
5.3.3 Bayer Drugs for Schistosomiasis Products Offered
5.3.4 Bayer Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Bayer Drugs for Schistosomiasis Sales by Product in 2024
5.3.6 Bayer Drugs for Schistosomiasis Sales by Application in 2024
5.3.7 Bayer Drugs for Schistosomiasis Sales by Geographic Area in 2024
5.3.8 Bayer Recent Developments
5.4 EIPICO
5.4.1 EIPICO Company Information
5.4.2 EIPICO Description, Business Overview
5.4.3 EIPICO Drugs for Schistosomiasis Products Offered
5.4.4 EIPICO Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2020-2025)
5.4.5 EIPICO Drugs for Schistosomiasis Sales by Product in 2024
5.4.6 EIPICO Drugs for Schistosomiasis Sales by Application in 2024
5.4.7 EIPICO Drugs for Schistosomiasis Sales by Geographic Area in 2024
5.4.8 EIPICO Recent Developments
5.5 Chandra Bhagat Pharma
5.5.1 Chandra Bhagat Pharma Company Information
5.5.2 Chandra Bhagat Pharma Description, Business Overview
5.5.3 Chandra Bhagat Pharma Drugs for Schistosomiasis Products Offered
5.5.4 Chandra Bhagat Pharma Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Chandra Bhagat Pharma Drugs for Schistosomiasis Sales by Product in 2024
5.5.6 Chandra Bhagat Pharma Drugs for Schistosomiasis Sales by Application in 2024
5.5.7 Chandra Bhagat Pharma Drugs for Schistosomiasis Sales by Geographic Area in 2024
5.5.8 Chandra Bhagat Pharma Recent Developments
5.6 Taj Pharmaceuticals
5.6.1 Taj Pharmaceuticals Company Information
5.6.2 Taj Pharmaceuticals Description, Business Overview
5.6.3 Taj Pharmaceuticals Drugs for Schistosomiasis Products Offered
5.6.4 Taj Pharmaceuticals Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Taj Pharmaceuticals Drugs for Schistosomiasis Sales by Product in 2024
5.6.6 Taj Pharmaceuticals Drugs for Schistosomiasis Sales by Application in 2024
5.6.7 Taj Pharmaceuticals Drugs for Schistosomiasis Sales by Geographic Area in 2024
5.6.8 Taj Pharmaceuticals Recent Developments
6 North America
6.1 North America Drugs for Schistosomiasis Market Size YoY Growth 2020-2031
6.2 North America Drugs for Schistosomiasis Market Facts & Figures by Country
6.2.1 North America Drugs for Schistosomiasis Sales by Country (2020-2031)
6.2.2 North America Drugs for Schistosomiasis Revenue by Country (2020-2031)
6.3 North America Drugs for Schistosomiasis Sales by Type (2020-2025)
6.4 North America Drugs for Schistosomiasis Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Drugs for Schistosomiasis Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Drugs for Schistosomiasis Market Facts & Figures by Region
7.2.1 Asia-Pacific Drugs for Schistosomiasis Sales by Region (2020-2031)
7.2.2 Asia-Pacific Drugs for Schistosomiasis Revenue by Region (2020-2031)
7.3 Asia-Pacific Drugs for Schistosomiasis Sales by Type (2020-2025)
7.4 Asia-Pacific Drugs for Schistosomiasis Sales by Application (2020-2025)
8 Europe
8.1 Europe Drugs for Schistosomiasis Market Size YoY Growth 2020-2031
8.2 Europe Drugs for Schistosomiasis Market Facts & Figures by Country
8.2.1 Europe Drugs for Schistosomiasis Sales by Country (2020-2031)
8.2.2 Europe Drugs for Schistosomiasis Revenue by Country (2020-2031)
8.3 Europe Drugs for Schistosomiasis Sales by Type (2020-2025)
8.4 Europe Drugs for Schistosomiasis Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Drugs for Schistosomiasis Market Size YoY Growth 2020-2031
9.2 Latin America Drugs for Schistosomiasis Market Facts & Figures by Country
9.2.1 Latin America Drugs for Schistosomiasis Sales by Country (2020-2031)
9.2.2 Latin America Drugs for Schistosomiasis Revenue by Country (2020-2031)
9.3 Latin America Drugs for Schistosomiasis Sales by Type (2020-2025)
9.4 Latin America Drugs for Schistosomiasis Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Drugs for Schistosomiasis Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Drugs for Schistosomiasis Market Facts & Figures by Country
10.2.1 Middle East and Africa Drugs for Schistosomiasis Sales by Country (2020-2031)
10.2.2 Middle East and Africa Drugs for Schistosomiasis Revenue by Country (2020-2031)
10.3 Middle East and Africa Drugs for Schistosomiasis Sales by Type (2020-2025)
10.4 Middle East and Africa Drugs for Schistosomiasis Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Drugs for Schistosomiasis Supply Chain Analysis
11.2 Drugs for Schistosomiasis Key Raw Materials and Upstream Suppliers
11.3 Drugs for Schistosomiasis Clients Analysis
11.4 Drugs for Schistosomiasis Sales Channel and Sales Model Analysis
11.4.1 Drugs for Schistosomiasis Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Drugs for Schistosomiasis Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Drugs for Schistosomiasis Distributors
12 Drugs for Schistosomiasis Market Dynamics
12.1 Drugs for Schistosomiasis Industry Trends
12.2 Drugs for Schistosomiasis Market Drivers
12.3 Drugs for Schistosomiasis Market Challenges
12.4 Drugs for Schistosomiasis Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Drugs for Schistosomiasis Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Drugs for Schistosomiasis Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Drugs for Schistosomiasis Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Drugs for Schistosomiasis Sales by Region (2020-2025) & (M Units)
Table 5. Global Drugs for Schistosomiasis Sales Forecast by Region (2026-2031) & (M Units)
Table 6. Global Drugs for Schistosomiasis Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Drugs for Schistosomiasis Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Drugs for Schistosomiasis Sales Volume by Type (2020-2025) & (M Units)
Table 9. Global Drugs for Schistosomiasis Sales Volume by Type (2026-2031) & (M Units)
Table 10. Global Drugs for Schistosomiasis Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Drugs for Schistosomiasis Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Drugs for Schistosomiasis Sales Volume by Application (2020-2025) & (M Units)
Table 13. Global Drugs for Schistosomiasis Sales Volume by Application (2026-2031) & (M Units)
Table 14. Global Drugs for Schistosomiasis Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Drugs for Schistosomiasis Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Drugs for Schistosomiasis Sales by Manufacturer (2020-2025) & (M Units)
Table 17. Global Drugs for Schistosomiasis Sales Share by Manufacturer (2020-2025)
Table 18. Drugs for Schistosomiasis Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Drugs for Schistosomiasis Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Drugs for Schistosomiasis Price (2020-2025) & (USD/K Units)
Table 21. Ranking of Global Top Drugs for Schistosomiasis Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Drugs for Schistosomiasis Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Drugs for Schistosomiasis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Schistosomiasis as of 2024)
Table 24. Drugs for Schistosomiasis Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Drugs for Schistosomiasis Market
Table 26. Manufacturers Drugs for Schistosomiasis Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Shin Poong Company Information
Table 29. Shin Poong Description and Business Overview
Table 30. Shin Poong Drugs for Schistosomiasis Product
Table 31. Shin Poong Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 32. Shin Poong Sales Proportion of Drugs for Schistosomiasis by Product in 2024
Table 33. Shin Poong Sales Proportion of Drugs for Schistosomiasis by Application in 2024
Table 34. Shin Poong Sales Proportion of Drugs for Schistosomiasis by Geographic Area in 2024
Table 35. Shin Poong Recent Developments
Table 36. Merck Company Information
Table 37. Merck Description and Business Overview
Table 38. Merck Drugs for Schistosomiasis Product
Table 39. Merck Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 40. Merck Sales Proportion of Drugs for Schistosomiasis by Product in 2024
Table 41. Merck Sales Proportion of Drugs for Schistosomiasis by Application in 2024
Table 42. Merck Sales Proportion of Drugs for Schistosomiasis by Geographic Area in 2024
Table 43. Merck Recent Developments
Table 44. Bayer Company Information
Table 45. Bayer Description and Business Overview
Table 46. Bayer Drugs for Schistosomiasis Product
Table 47. Bayer Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 48. Bayer Sales Proportion of Drugs for Schistosomiasis by Product in 2024
Table 49. Bayer Sales Proportion of Drugs for Schistosomiasis by Application in 2024
Table 50. Bayer Sales Proportion of Drugs for Schistosomiasis by Geographic Area in 2024
Table 51. Bayer Recent Developments
Table 52. EIPICO Company Information
Table 53. EIPICO Description and Business Overview
Table 54. EIPICO Drugs for Schistosomiasis Product
Table 55. EIPICO Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 56. EIPICO Sales Proportion of Drugs for Schistosomiasis by Product in 2024
Table 57. EIPICO Sales Proportion of Drugs for Schistosomiasis by Application in 2024
Table 58. EIPICO Sales Proportion of Drugs for Schistosomiasis by Geographic Area in 2024
Table 59. EIPICO Recent Developments
Table 60. Chandra Bhagat Pharma Company Information
Table 61. Chandra Bhagat Pharma Description and Business Overview
Table 62. Chandra Bhagat Pharma Drugs for Schistosomiasis Product
Table 63. Chandra Bhagat Pharma Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 64. Chandra Bhagat Pharma Sales Proportion of Drugs for Schistosomiasis by Product in 2024
Table 65. Chandra Bhagat Pharma Sales Proportion of Drugs for Schistosomiasis by Application in 2024
Table 66. Chandra Bhagat Pharma Sales Proportion of Drugs for Schistosomiasis by Geographic Area in 2024
Table 67. Chandra Bhagat Pharma Recent Developments
Table 68. Taj Pharmaceuticals Company Information
Table 69. Taj Pharmaceuticals Description and Business Overview
Table 70. Taj Pharmaceuticals Drugs for Schistosomiasis Product
Table 71. Taj Pharmaceuticals Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 72. Taj Pharmaceuticals Sales Proportion of Drugs for Schistosomiasis by Product in 2024
Table 73. Taj Pharmaceuticals Sales Proportion of Drugs for Schistosomiasis by Application in 2024
Table 74. Taj Pharmaceuticals Sales Proportion of Drugs for Schistosomiasis by Geographic Area in 2024
Table 75. Taj Pharmaceuticals Recent Developments
Table 76. North America Drugs for Schistosomiasis Sales by Country (2020-2025) & (M Units)
Table 77. North America Drugs for Schistosomiasis Sales by Country (2026-2031) & (M Units)
Table 78. North America Drugs for Schistosomiasis Revenue by Country (2020-2025) & (US$ Million)
Table 79. North America Drugs for Schistosomiasis Revenue by Country (2026-2031) & (US$ Million)
Table 80. North America Drugs for Schistosomiasis Sales by Type (2020-2025) & (M Units)
Table 81. North America Drugs for Schistosomiasis Sales by Application (2020-2025) & (M Units)
Table 82. Asia-Pacific Drugs for Schistosomiasis Sales by Region (2020-2025) & (M Units)
Table 83. Asia-Pacific Drugs for Schistosomiasis Sales by Region (2026-2031) & (M Units)
Table 84. Asia-Pacific Drugs for Schistosomiasis Revenue by Region (2020-2025) & (US$ Million)
Table 85. Asia-Pacific Drugs for Schistosomiasis Revenue by Region (2026-2031) & (US$ Million)
Table 86. Asia-Pacific Drugs for Schistosomiasis Sales by Type (2020-2025) & (M Units)
Table 87. Asia-Pacific Drugs for Schistosomiasis Sales by Application (2020-2025) & (M Units)
Table 88. Europe Drugs for Schistosomiasis Sales by Country (2020-2025) & (M Units)
Table 89. Europe Drugs for Schistosomiasis Sales by Country (2026-2031) & (M Units)
Table 90. Europe Drugs for Schistosomiasis Revenue by Country (2020-2025) & (US$ Million)
Table 91. Europe Drugs for Schistosomiasis Revenue by Country (2026-2031) & (US$ Million)
Table 92. Europe Drugs for Schistosomiasis Sales by Type (2020-2025) & (M Units)
Table 93. Europe Drugs for Schistosomiasis Sales by Application (2020-2025) & (M Units)
Table 94. Latin America Drugs for Schistosomiasis Sales by Country (2020-2025) & (M Units)
Table 95. Latin America Drugs for Schistosomiasis Sales by Country (2026-2031) & (M Units)
Table 96. Latin America Drugs for Schistosomiasis Revenue by Country (2020-2025) & (US$ Million)
Table 97. Latin America Drugs for Schistosomiasis Revenue by Country (2026-2031) & (US$ Million)
Table 98. Latin America Drugs for Schistosomiasis Sales by Type (2020-2025) & (M Units)
Table 99. Latin America Drugs for Schistosomiasis Sales by Application (2020-2025) & (M Units)
Table 100. Middle East and Africa Drugs for Schistosomiasis Sales by Country (2020-2025) & (M Units)
Table 101. Middle East and Africa Drugs for Schistosomiasis Sales by Country (2026-2031) & (M Units)
Table 102. Middle East and Africa Drugs for Schistosomiasis Revenue by Country (2020-2025) & (US$ Million)
Table 103. Middle East and Africa Drugs for Schistosomiasis Revenue by Country (2026-2031) & (US$ Million)
Table 104. Middle East and Africa Drugs for Schistosomiasis Sales by Type (2020-2025) & (M Units)
Table 105. Middle East and Africa Drugs for Schistosomiasis Sales by Application (2020-2025) & (M Units)
Table 106. Drugs for Schistosomiasis Key Raw Materials, Industry Status and Trend
Table 107. Drugs for Schistosomiasis Key Raw Materials and Upstream Suppliers
Table 108. Drugs for Schistosomiasis Clients Status and Trend
Table 109. Drugs for Schistosomiasis Typical Clients
Table 110. Drugs for Schistosomiasis Distributors
Table 111. Drugs for Schistosomiasis Market Trends
Table 112. Drugs for Schistosomiasis Market Drivers
Table 113. Drugs for Schistosomiasis Market Challenges
Table 114. Drugs for Schistosomiasis Market Restraints
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
Table 118. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Drugs for Schistosomiasis Product Picture
Figure 2. Global Drugs for Schistosomiasis Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Drugs for Schistosomiasis Sales Market Share by Type in 2024 & 2031
Figure 4. Praziquantel Product Picture
Figure 5. Oxamniquine Product Picture
Figure 6. Other Product Picture
Figure 7. Global Drugs for Schistosomiasis Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Drugs for Schistosomiasis Sales Market Share by Application in 2024 & 2031
Figure 9. S. haematobium
Figure 10. S. mansoni
Figure 11. S. japonicum
Figure 12. S. mekongi
Figure 13. S. intercalatum
Figure 14. Drugs for Schistosomiasis Report Years Considered
Figure 15. Global Drugs for Schistosomiasis Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Drugs for Schistosomiasis Market Size 2020-2031 (US$ Million)
Figure 17. Global Drugs for Schistosomiasis Sales 2020-2031 (M Units)
Figure 18. Global Drugs for Schistosomiasis Sales Market Share Forecast by Region (2020-2031)
Figure 19. Global Drugs for Schistosomiasis Revenue Market Share by Region (2020-2031)
Figure 20. Global Drugs for Schistosomiasis Sales Market Share Forecast by Type (2020-2031)
Figure 21. Global Drugs for Schistosomiasis Revenue Market Share Forecast by Type (2020-2031)
Figure 22. Drugs for Schistosomiasis Average Selling Price (ASP) by Type (2020-2025) & (USD/K Units)
Figure 23. Global Drugs for Schistosomiasis Sales Market Share Forecast by Application (2020-2031)
Figure 24. Global Drugs for Schistosomiasis Revenue Market Share Forecast by Application (2020-2031)
Figure 25. Drugs for Schistosomiasis Average Selling Price (ASP) by Application (2020-2025) & (USD/K Units)
Figure 26. Praziquantel of Drugs for Schistosomiasis Revenue Market Share by Application, 2024 VS 2031
Figure 27. Oxamniquine of Drugs for Schistosomiasis Revenue Market Share by Application, 2024 VS 2031
Figure 28. Other of Drugs for Schistosomiasis Revenue Market Share by Application, 2024 VS 2031
Figure 29. Global Drugs for Schistosomiasis Sales Share by Manufacturer in 2024
Figure 30. Drugs for Schistosomiasis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 31. Praziquantel Market Sales Proportion by Manufacturer in 2024
Figure 32. Oxamniquine Market Sales Proportion by Manufacturer in 2024
Figure 33. Other Market Sales Proportion by Manufacturer in 2024
Figure 34. North America Drugs for Schistosomiasis Revenue 2020-2031 (US$ Million)
Figure 35. North America Drugs for Schistosomiasis Sales Market Share by Type (2020-2025)
Figure 36. North America Drugs for Schistosomiasis Sales Market Share by Application (2020-2025)
Figure 37. Asia-Pacific Drugs for Schistosomiasis Revenue 2020-2031 (US$ Million)
Figure 38. Asia-Pacific Drugs for Schistosomiasis Sales Market Share by Region (2020-2031)
Figure 39. Asia-Pacific Drugs for Schistosomiasis Revenue Market Share by Region (2020-2031)
Figure 40. Asia-Pacific Drugs for Schistosomiasis Sales Market Share by Type (2020-2025)
Figure 41. Asia-Pacific Drugs for Schistosomiasis Sales Market Share by Application (2020-2025)
Figure 42. Europe Drugs for Schistosomiasis Revenue Growth Rate 2020-2031 (US$ Million)
Figure 43. Europe Drugs for Schistosomiasis Sales Market Share by Country (2020-2031)
Figure 44. Europe Drugs for Schistosomiasis Revenue Market Share by Country (2020-2031)
Figure 45. Europe Drugs for Schistosomiasis Sales Market Share by Type (2020-2025)
Figure 46. Europe Drugs for Schistosomiasis Sales Market Share by Application (2020-2025)
Figure 47. Latin America Drugs for Schistosomiasis Revenue Growth Rate 2020-2031 (US$ Million)
Figure 48. Latin America Drugs for Schistosomiasis Sales Market Share by Country (2020-2031)
Figure 49. Latin America Drugs for Schistosomiasis Revenue Market Share by Country (2020-2025)
Figure 50. Latin America Drugs for Schistosomiasis Sales Market Share by Type (2020-2025)
Figure 51. Latin America Drugs for Schistosomiasis Sales Market Share by Application (2020-2025)
Figure 52. Middle East and Africa Drugs for Schistosomiasis Revenue Growth Rate 2020-2031 (US$ Million)
Figure 53. Middle East and Africa Drugs for Schistosomiasis Sales Market Share by Country (2020-2031)
Figure 54. Middle East and Africa Drugs for Schistosomiasis Revenue Market Share by Country (2020-2031)
Figure 55. Middle East and Africa Drugs for Schistosomiasis Sales Market Share by Type (2020-2025)
Figure 56. Middle East and Africa Drugs for Schistosomiasis Sales Market Share by Application (2020-2025)
Figure 57. Drugs for Schistosomiasis Supply Chain (Upstream and Downstream Market)
Figure 58. Global Production Market Share of Drugs for Schistosomiasis Raw Materials by Region in 2024
Figure 59. Drugs for Schistosomiasis Distribution Channels
Figure 60. Global Drugs for Schistosomiasis Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 61. Global Drugs for Schistosomiasis Percentage 2020-2031: Online Sales VS Offline Sales
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Drugs for Schistosomiasis Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Drugs for Schistosomiasis Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Drugs for Schistosomiasis Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Drugs for Schistosomiasis Sales by Region (2020-2025) & (M Units)
Table 5. Global Drugs for Schistosomiasis Sales Forecast by Region (2026-2031) & (M Units)
Table 6. Global Drugs for Schistosomiasis Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Drugs for Schistosomiasis Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Drugs for Schistosomiasis Sales Volume by Type (2020-2025) & (M Units)
Table 9. Global Drugs for Schistosomiasis Sales Volume by Type (2026-2031) & (M Units)
Table 10. Global Drugs for Schistosomiasis Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Drugs for Schistosomiasis Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Drugs for Schistosomiasis Sales Volume by Application (2020-2025) & (M Units)
Table 13. Global Drugs for Schistosomiasis Sales Volume by Application (2026-2031) & (M Units)
Table 14. Global Drugs for Schistosomiasis Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Drugs for Schistosomiasis Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Drugs for Schistosomiasis Sales by Manufacturer (2020-2025) & (M Units)
Table 17. Global Drugs for Schistosomiasis Sales Share by Manufacturer (2020-2025)
Table 18. Drugs for Schistosomiasis Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Drugs for Schistosomiasis Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Drugs for Schistosomiasis Price (2020-2025) & (USD/K Units)
Table 21. Ranking of Global Top Drugs for Schistosomiasis Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Drugs for Schistosomiasis Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Drugs for Schistosomiasis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Schistosomiasis as of 2024)
Table 24. Drugs for Schistosomiasis Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Drugs for Schistosomiasis Market
Table 26. Manufacturers Drugs for Schistosomiasis Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Shin Poong Company Information
Table 29. Shin Poong Description and Business Overview
Table 30. Shin Poong Drugs for Schistosomiasis Product
Table 31. Shin Poong Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 32. Shin Poong Sales Proportion of Drugs for Schistosomiasis by Product in 2024
Table 33. Shin Poong Sales Proportion of Drugs for Schistosomiasis by Application in 2024
Table 34. Shin Poong Sales Proportion of Drugs for Schistosomiasis by Geographic Area in 2024
Table 35. Shin Poong Recent Developments
Table 36. Merck Company Information
Table 37. Merck Description and Business Overview
Table 38. Merck Drugs for Schistosomiasis Product
Table 39. Merck Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 40. Merck Sales Proportion of Drugs for Schistosomiasis by Product in 2024
Table 41. Merck Sales Proportion of Drugs for Schistosomiasis by Application in 2024
Table 42. Merck Sales Proportion of Drugs for Schistosomiasis by Geographic Area in 2024
Table 43. Merck Recent Developments
Table 44. Bayer Company Information
Table 45. Bayer Description and Business Overview
Table 46. Bayer Drugs for Schistosomiasis Product
Table 47. Bayer Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 48. Bayer Sales Proportion of Drugs for Schistosomiasis by Product in 2024
Table 49. Bayer Sales Proportion of Drugs for Schistosomiasis by Application in 2024
Table 50. Bayer Sales Proportion of Drugs for Schistosomiasis by Geographic Area in 2024
Table 51. Bayer Recent Developments
Table 52. EIPICO Company Information
Table 53. EIPICO Description and Business Overview
Table 54. EIPICO Drugs for Schistosomiasis Product
Table 55. EIPICO Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 56. EIPICO Sales Proportion of Drugs for Schistosomiasis by Product in 2024
Table 57. EIPICO Sales Proportion of Drugs for Schistosomiasis by Application in 2024
Table 58. EIPICO Sales Proportion of Drugs for Schistosomiasis by Geographic Area in 2024
Table 59. EIPICO Recent Developments
Table 60. Chandra Bhagat Pharma Company Information
Table 61. Chandra Bhagat Pharma Description and Business Overview
Table 62. Chandra Bhagat Pharma Drugs for Schistosomiasis Product
Table 63. Chandra Bhagat Pharma Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 64. Chandra Bhagat Pharma Sales Proportion of Drugs for Schistosomiasis by Product in 2024
Table 65. Chandra Bhagat Pharma Sales Proportion of Drugs for Schistosomiasis by Application in 2024
Table 66. Chandra Bhagat Pharma Sales Proportion of Drugs for Schistosomiasis by Geographic Area in 2024
Table 67. Chandra Bhagat Pharma Recent Developments
Table 68. Taj Pharmaceuticals Company Information
Table 69. Taj Pharmaceuticals Description and Business Overview
Table 70. Taj Pharmaceuticals Drugs for Schistosomiasis Product
Table 71. Taj Pharmaceuticals Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 72. Taj Pharmaceuticals Sales Proportion of Drugs for Schistosomiasis by Product in 2024
Table 73. Taj Pharmaceuticals Sales Proportion of Drugs for Schistosomiasis by Application in 2024
Table 74. Taj Pharmaceuticals Sales Proportion of Drugs for Schistosomiasis by Geographic Area in 2024
Table 75. Taj Pharmaceuticals Recent Developments
Table 76. North America Drugs for Schistosomiasis Sales by Country (2020-2025) & (M Units)
Table 77. North America Drugs for Schistosomiasis Sales by Country (2026-2031) & (M Units)
Table 78. North America Drugs for Schistosomiasis Revenue by Country (2020-2025) & (US$ Million)
Table 79. North America Drugs for Schistosomiasis Revenue by Country (2026-2031) & (US$ Million)
Table 80. North America Drugs for Schistosomiasis Sales by Type (2020-2025) & (M Units)
Table 81. North America Drugs for Schistosomiasis Sales by Application (2020-2025) & (M Units)
Table 82. Asia-Pacific Drugs for Schistosomiasis Sales by Region (2020-2025) & (M Units)
Table 83. Asia-Pacific Drugs for Schistosomiasis Sales by Region (2026-2031) & (M Units)
Table 84. Asia-Pacific Drugs for Schistosomiasis Revenue by Region (2020-2025) & (US$ Million)
Table 85. Asia-Pacific Drugs for Schistosomiasis Revenue by Region (2026-2031) & (US$ Million)
Table 86. Asia-Pacific Drugs for Schistosomiasis Sales by Type (2020-2025) & (M Units)
Table 87. Asia-Pacific Drugs for Schistosomiasis Sales by Application (2020-2025) & (M Units)
Table 88. Europe Drugs for Schistosomiasis Sales by Country (2020-2025) & (M Units)
Table 89. Europe Drugs for Schistosomiasis Sales by Country (2026-2031) & (M Units)
Table 90. Europe Drugs for Schistosomiasis Revenue by Country (2020-2025) & (US$ Million)
Table 91. Europe Drugs for Schistosomiasis Revenue by Country (2026-2031) & (US$ Million)
Table 92. Europe Drugs for Schistosomiasis Sales by Type (2020-2025) & (M Units)
Table 93. Europe Drugs for Schistosomiasis Sales by Application (2020-2025) & (M Units)
Table 94. Latin America Drugs for Schistosomiasis Sales by Country (2020-2025) & (M Units)
Table 95. Latin America Drugs for Schistosomiasis Sales by Country (2026-2031) & (M Units)
Table 96. Latin America Drugs for Schistosomiasis Revenue by Country (2020-2025) & (US$ Million)
Table 97. Latin America Drugs for Schistosomiasis Revenue by Country (2026-2031) & (US$ Million)
Table 98. Latin America Drugs for Schistosomiasis Sales by Type (2020-2025) & (M Units)
Table 99. Latin America Drugs for Schistosomiasis Sales by Application (2020-2025) & (M Units)
Table 100. Middle East and Africa Drugs for Schistosomiasis Sales by Country (2020-2025) & (M Units)
Table 101. Middle East and Africa Drugs for Schistosomiasis Sales by Country (2026-2031) & (M Units)
Table 102. Middle East and Africa Drugs for Schistosomiasis Revenue by Country (2020-2025) & (US$ Million)
Table 103. Middle East and Africa Drugs for Schistosomiasis Revenue by Country (2026-2031) & (US$ Million)
Table 104. Middle East and Africa Drugs for Schistosomiasis Sales by Type (2020-2025) & (M Units)
Table 105. Middle East and Africa Drugs for Schistosomiasis Sales by Application (2020-2025) & (M Units)
Table 106. Drugs for Schistosomiasis Key Raw Materials, Industry Status and Trend
Table 107. Drugs for Schistosomiasis Key Raw Materials and Upstream Suppliers
Table 108. Drugs for Schistosomiasis Clients Status and Trend
Table 109. Drugs for Schistosomiasis Typical Clients
Table 110. Drugs for Schistosomiasis Distributors
Table 111. Drugs for Schistosomiasis Market Trends
Table 112. Drugs for Schistosomiasis Market Drivers
Table 113. Drugs for Schistosomiasis Market Challenges
Table 114. Drugs for Schistosomiasis Market Restraints
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
Table 118. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Drugs for Schistosomiasis Product Picture
Figure 2. Global Drugs for Schistosomiasis Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Drugs for Schistosomiasis Sales Market Share by Type in 2024 & 2031
Figure 4. Praziquantel Product Picture
Figure 5. Oxamniquine Product Picture
Figure 6. Other Product Picture
Figure 7. Global Drugs for Schistosomiasis Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Drugs for Schistosomiasis Sales Market Share by Application in 2024 & 2031
Figure 9. S. haematobium
Figure 10. S. mansoni
Figure 11. S. japonicum
Figure 12. S. mekongi
Figure 13. S. intercalatum
Figure 14. Drugs for Schistosomiasis Report Years Considered
Figure 15. Global Drugs for Schistosomiasis Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Drugs for Schistosomiasis Market Size 2020-2031 (US$ Million)
Figure 17. Global Drugs for Schistosomiasis Sales 2020-2031 (M Units)
Figure 18. Global Drugs for Schistosomiasis Sales Market Share Forecast by Region (2020-2031)
Figure 19. Global Drugs for Schistosomiasis Revenue Market Share by Region (2020-2031)
Figure 20. Global Drugs for Schistosomiasis Sales Market Share Forecast by Type (2020-2031)
Figure 21. Global Drugs for Schistosomiasis Revenue Market Share Forecast by Type (2020-2031)
Figure 22. Drugs for Schistosomiasis Average Selling Price (ASP) by Type (2020-2025) & (USD/K Units)
Figure 23. Global Drugs for Schistosomiasis Sales Market Share Forecast by Application (2020-2031)
Figure 24. Global Drugs for Schistosomiasis Revenue Market Share Forecast by Application (2020-2031)
Figure 25. Drugs for Schistosomiasis Average Selling Price (ASP) by Application (2020-2025) & (USD/K Units)
Figure 26. Praziquantel of Drugs for Schistosomiasis Revenue Market Share by Application, 2024 VS 2031
Figure 27. Oxamniquine of Drugs for Schistosomiasis Revenue Market Share by Application, 2024 VS 2031
Figure 28. Other of Drugs for Schistosomiasis Revenue Market Share by Application, 2024 VS 2031
Figure 29. Global Drugs for Schistosomiasis Sales Share by Manufacturer in 2024
Figure 30. Drugs for Schistosomiasis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 31. Praziquantel Market Sales Proportion by Manufacturer in 2024
Figure 32. Oxamniquine Market Sales Proportion by Manufacturer in 2024
Figure 33. Other Market Sales Proportion by Manufacturer in 2024
Figure 34. North America Drugs for Schistosomiasis Revenue 2020-2031 (US$ Million)
Figure 35. North America Drugs for Schistosomiasis Sales Market Share by Type (2020-2025)
Figure 36. North America Drugs for Schistosomiasis Sales Market Share by Application (2020-2025)
Figure 37. Asia-Pacific Drugs for Schistosomiasis Revenue 2020-2031 (US$ Million)
Figure 38. Asia-Pacific Drugs for Schistosomiasis Sales Market Share by Region (2020-2031)
Figure 39. Asia-Pacific Drugs for Schistosomiasis Revenue Market Share by Region (2020-2031)
Figure 40. Asia-Pacific Drugs for Schistosomiasis Sales Market Share by Type (2020-2025)
Figure 41. Asia-Pacific Drugs for Schistosomiasis Sales Market Share by Application (2020-2025)
Figure 42. Europe Drugs for Schistosomiasis Revenue Growth Rate 2020-2031 (US$ Million)
Figure 43. Europe Drugs for Schistosomiasis Sales Market Share by Country (2020-2031)
Figure 44. Europe Drugs for Schistosomiasis Revenue Market Share by Country (2020-2031)
Figure 45. Europe Drugs for Schistosomiasis Sales Market Share by Type (2020-2025)
Figure 46. Europe Drugs for Schistosomiasis Sales Market Share by Application (2020-2025)
Figure 47. Latin America Drugs for Schistosomiasis Revenue Growth Rate 2020-2031 (US$ Million)
Figure 48. Latin America Drugs for Schistosomiasis Sales Market Share by Country (2020-2031)
Figure 49. Latin America Drugs for Schistosomiasis Revenue Market Share by Country (2020-2025)
Figure 50. Latin America Drugs for Schistosomiasis Sales Market Share by Type (2020-2025)
Figure 51. Latin America Drugs for Schistosomiasis Sales Market Share by Application (2020-2025)
Figure 52. Middle East and Africa Drugs for Schistosomiasis Revenue Growth Rate 2020-2031 (US$ Million)
Figure 53. Middle East and Africa Drugs for Schistosomiasis Sales Market Share by Country (2020-2031)
Figure 54. Middle East and Africa Drugs for Schistosomiasis Revenue Market Share by Country (2020-2031)
Figure 55. Middle East and Africa Drugs for Schistosomiasis Sales Market Share by Type (2020-2025)
Figure 56. Middle East and Africa Drugs for Schistosomiasis Sales Market Share by Application (2020-2025)
Figure 57. Drugs for Schistosomiasis Supply Chain (Upstream and Downstream Market)
Figure 58. Global Production Market Share of Drugs for Schistosomiasis Raw Materials by Region in 2024
Figure 59. Drugs for Schistosomiasis Distribution Channels
Figure 60. Global Drugs for Schistosomiasis Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 61. Global Drugs for Schistosomiasis Percentage 2020-2031: Online Sales VS Offline Sales
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Medical Waste Fluid Solidifier Market Research Report 2025
Jun 12, 25
Global Metalized Bubble Material Market Research Report 2025
Jun 12, 25
Global 70% Isopropyl Rubbing Alcohol Market Research Report 2025
Jun 12, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232